Knowles D M, Jakobiec F A, Wang C Y
Am J Ophthalmol. 1982 Aug;94(2):246-54. doi: 10.1016/0002-9394(82)90082-4.
Leu 1 is a surface membrane antigen expressed by benign systemic T cells, most cases of B-cell-derived chronic lymphocytic leukemia, and approximately one half of the systemic B-cell lymphomas. Benign systemic B cells are Leu 1-. Our studies showed that the percentage of Leu 1+ cells was essentially the same as the percentage of OKT3+E+ (T) cells in six ocular adnexal pseudolymphomas, strongly suggesting that the benign B cells in these lesions were similarly Leu 1-. These studies also showed that malignant B cells in six of 15 (40%) ocular B-cell lymphomas were Leu 1+. Thus, the expression of Leu 1 by some malignant ocular adnexal B cells but not by benign ocular adnexal B cells appears to be analogous to the situation for lymph nodal and other systemic B cells. Although the explanation for the existence of this shared determinant is unknown, Leu 1 expression may possess clinical and diagnostic significance as a marker of neoplastic B cells.
Leu 1是一种表面膜抗原,由良性系统性T细胞、大多数B细胞来源的慢性淋巴细胞白血病病例以及大约一半的系统性B细胞淋巴瘤表达。良性系统性B细胞不表达Leu 1。我们的研究表明,在6例眼附属器假性淋巴瘤中,Leu 1+细胞的百分比与OKT3+E+(T)细胞的百分比基本相同,这强烈表明这些病变中的良性B细胞同样不表达Leu 1。这些研究还表明,15例眼B细胞淋巴瘤中有6例(40%)的恶性B细胞表达Leu 1。因此,一些恶性眼附属器B细胞表达Leu 1而良性眼附属器B细胞不表达,这似乎与淋巴结和其他系统性B细胞的情况类似。尽管这种共同决定簇存在的原因尚不清楚,但Leu 1表达作为肿瘤性B细胞的标志物可能具有临床和诊断意义。